Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Brammer Biopharmaceuticals

2015 FOUNDED
M&A STATUS
301-400 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
1 INVESTMENTS
Description

Provider of best-in-class cell and gene therapy designed to improve patient health. The company's cell and gene therapy enabling pharmaceuticals and biotech clients to accelerate the delivery of novel medicines.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Acquirer
Primary Office
  • PO Box 267
  • Lexington, MA 02420
  • United States

Brammer Biopharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Brammer Biopharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Brammer Biopharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 (0000000000 01-Jan-2017 000000000000000000 Other Business Products and Services
To view this company’s complete investment and acquisition history, request access »

Brammer Biopharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Steven Kasok Co-Founder & Chief Financial Officer
Mark Bamforth Co-Founder, President & Chief Executive Officer